AAAAAA

   
Results: 1-10 |
Results: 10
Maintenance of naive and Th1CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens
Authors: Meroni, L Manganaro, D Varchetta, S Gatti, N Riva, A Monforte, AD Galli, M
Citation: L. Meroni et al., Maintenance of naive and Th1CD4 phenotype and lack of CD8 activation in patients switching from protease inhibitors to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimens, J ACQ IMM D, 28(4), 2001, pp. 401-403
Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen
Authors: Monforte, AD Adorni, F Meroni, L Bini, T Testa, L Chiesa, E Melzi, S Rusconi, S Sollima, S Galli, M Moroni, M
Citation: Ad. Monforte et al., Predictive role of the three-month CD4 cell count in the long-term clinical outcome of the first HAART regimen, BIOMED PHAR, 55(1), 2001, pp. 16-22
Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein
Authors: Zehender, G Varchetta, S De Maddalena, C Colasante, C Riva, A Meroni, L Moroni, M Galli, M
Citation: G. Zehender et al., Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein, VIROLOGY, 281(1), 2001, pp. 43-50
Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy
Authors: Corbellino, M Bestetti, G Scalamogna, C Calattini, S Galazzi, M Meroni, L Manganaro, D Fasan, M Moroni, M Galli, M Parravicini, C
Citation: M. Corbellino et al., Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy, BLOOD, 98(12), 2001, pp. 3473-3475
Thyroid nodules and carcinoma in Graves disease - Reply
Authors: Cantalamessa, L Baldini, M Orsatti, A Meroni, L Amodei, V Castagnone, D
Citation: L. Cantalamessa et al., Thyroid nodules and carcinoma in Graves disease - Reply, ARCH IN MED, 160(10), 2000, pp. 1541-1541
Altered signaling lymphocytic activation molecule (SLAM) expression in HIVinfection and redirection of HIV-specific responses via SLAM triggering
Authors: Meroni, L Fusi, ML Varchetta, S Biasin, M Rusconi, S Villa, ML De Vries, JE Aversa, G Galli, M Clerici, M
Citation: L. Meroni et al., Altered signaling lymphocytic activation molecule (SLAM) expression in HIVinfection and redirection of HIV-specific responses via SLAM triggering, CLIN IMMUNO, 92(3), 1999, pp. 276-284
CD4+CD7- lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy
Authors: Meroni, L Varchetta, S Manganaro, D Moscatelli, G Moroni, M Galli, M
Citation: L. Meroni et al., CD4+CD7- lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy, AIDS, 13(5), 1999, pp. 621-622
CD4 cell counts at the third month of HAART may predict clinical failure
Authors: Monforte, AD Testori, V Adorni, F Castelnuovo, B Bini, T Testa, L Moscatelli, G Chiesa, E Rusconi, S Abeli, C Sollima, S Musicco, M Meroni, L Galli, M Moroni, M
Citation: Ad. Monforte et al., CD4 cell counts at the third month of HAART may predict clinical failure, AIDS, 13(13), 1999, pp. 1669-1676
Thyroid nodules in Graves disease and the risk of thyroid carcinoma
Authors: Cantalamessa, L Baldini, M Orsatti, A Meroni, L Amodei, V Castagnone, D
Citation: L. Cantalamessa et al., Thyroid nodules in Graves disease and the risk of thyroid carcinoma, ARCH IN MED, 159(15), 1999, pp. 1705-1708
Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy
Authors: Galli, M Balotta, C Meroni, L Colombo, MC Papagno, L Bagnarelli, P Testa, L Varchetta, S Colombo, L Moroni, M Monforte, AD Clerici, M Clementi, M
Citation: M. Galli et al., Early increase in cell-associated HIV-1 DNA in patients on highly active antiretroviral therapy, AIDS, 12(18), 1998, pp. 2500-2502
Risultati: 1-10 |